NCT01078519

Brief Summary

Maternal intra-partum fever commonly complicates the process of labour. Its occurrence is often regarded as being synonymous with the presence of chorioamnionitis. This inevitably results in the administration of antibiotics to the affected mother. Review of the literature however suggests that this approach is not always appropriate. Non-infective causes of this condition that are often overlooked include the use of epidural analgesia for pain relief, normal thermal physiological changes in women not using any form of analgesia and delivery in an overheated room. Women with certain risk factors such as nulliparity and a long latent phase of labour are also more prone to developing maternal intra-partum fever. Irrespective of its aetiology, maternal intra-partum fever carries risks both for the mother and her unborn child. Putting more thought into the care of these patients will go a long way in reducing the maternal and neonatal morbidity associated with this complication.The combined spinal-epidural (CSE) technique has been introduced in an attempt to reduce these adverse effects. CSE is believed to during labour provide more rapid onset of analgesia than epidural analgesia, The incidence of fever is significantly lower with CSE technique.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jan 2010

Shorter than P25 for phase_3

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 25, 2010

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 2, 2010

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2010

Completed
Last Updated

July 15, 2010

Status Verified

December 1, 2007

Enrollment Period

5 months

First QC Date

February 25, 2010

Last Update Submit

July 14, 2010

Conditions

Keywords

FeveranesthesiaLabor

Outcome Measures

Primary Outcomes (1)

  • Fever frequency

    We will measure the temperature each hour

    each hour

Secondary Outcomes (1)

  • Incidence of c-section and instrumental delivery

    within the delivery

Study Arms (2)

Massages baths

NO INTERVENTION

doulas, massages and baths

Combined spinal-epidural anesthesia

ACTIVE COMPARATOR

local anesthetics in low doses with opioids

Drug: Combined epidural and spinal anesthesia

Interventions

Obstetrics patients will relieve spinal anesthesia with local anesthesics and opioids associated with epidural anesthesia with local anesthetics in low concentrations with opioids

Also known as: Local anesthetics, spinal opioides
Combined spinal-epidural anesthesia

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • singleton pregnancies
  • babies were presenting head first
  • were expecting a vaginal delivery single fetal
  • gestational age up to 37 weeks
  • cervix length between 3-6 cm

You may not qualify if:

  • Maternal fever before randomization
  • Antibiotics before randomization
  • haemostatic disorders during pregnancy
  • severe preeclâmpsia-eclampsia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Fever

Interventions

Anesthesia, SpinalAnesthetics, Local

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and AnalgesiaAnestheticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic Uses

Study Officials

  • Flavia A Orange

    IMIP

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 25, 2010

First Posted

March 2, 2010

Study Start

January 1, 2010

Primary Completion

June 1, 2010

Study Completion

June 1, 2010

Last Updated

July 15, 2010

Record last verified: 2007-12